Environmental Metals and Cardiovascular Disease in Adults: A Systematic Review Beyond Lead and Cadmium

被引：102
作者：
Nigra A.E. [1 ,2 ,3 ]
Ruiz-Hernandez A. [4 ,5 ]
Redon J. [4 ,5 ,6 ]
Navas-Acien A. [1 ,2 ,3 ,7 ]
Tellez-Plaza M. [1 ,5 ]
机构：
[1] Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
[2] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
[3] Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 W 168th St, 11 Floor Rm 1105, New York, 10032, NY
[4] Department of Internal Medicine, Hospital Clínico de Valencia, Avenida Blasco Ibañez, 17, Valencia
[5] Area of Cardiometabolic and Renal Risk, Institute for Biomedical Research Hospital Clinical of Valencia (INCLIVA), Av. Menendez Pelayo, 4 accesorio, Valencia
[6] CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Minister of Health, Madrid
[7] Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD
来源：
Current Environmental Health Reports | 2016年 / 3卷 / 4期
关键词：
Atherosclerosis; Cardiovascular; Epidemiologic studies; Metals; Systematic review;
D O I：
10.1007/s40572-016-0117-9
中图分类号：
学科分类号：
摘要：
Published systematic reviews concluded that there is moderate to strong evidence to infer a potential role of lead and cadmium, widespread environmental metals, as cardiovascular risk factors. For other non-essential metals, the evidence has not been appraised systematically. Our objective was to systematically review epidemiologic studies on the association between cardiovascular disease in adults and the environmental metals antimony, barium, chromium, nickel, tungsten, uranium, and vanadium. We identified a total of 4 articles on antimony, 1 on barium, 5 on chromium, 1 on nickel, 4 on tungsten, 1 on uranium, and 0 on vanadium. We concluded that the current evidence is not sufficient to inform on the cardiovascular role of these metals because of the small number of studies. Few experimental studies have also evaluated the role of these metals in cardiovascular outcomes. Additional epidemiologic and experimental studies, including prospective cohort studies, are needed to understand the role of metals, including exposure to metal mixtures, in cardiovascular disease development. © 2016, Springer International Publishing AG.
引用
收藏
页码：416 / 433
页数：17
相关论文
共 162 条
  • [91] Alvarez M., Malecot C.O., Gannier F., Lignon J.M., Antimony-induced cardiomyopathy in guinea-pig and protection by L-carnitine, Br J Pharmacol, 144, pp. 17-27, (2005)
  • [92] Greenwood N.N., Earnshaw A., Chemistry of the Elements, (1997)
  • [93] Gonzalez A.R., Ndung'u K., Flegal A.R., Natural occurrence of hexavalent chromium in the Aromas Red Sands Aquifer, California Environ Sci Technol, 39, pp. 5505-5511, (2005)
  • [94] Costello R.B., Dwyer J.T., Bailey R.L., Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness, Nutr Rev, 74, pp. 455-468, (2016)
  • [95] Althuis M.D., Jordan N.E., Ludington E.A., Wittes J.T., Glucose and insulin responses to dietary chromium supplements: a meta-analysis, Am J Clin Nutr, 76, pp. 148-155, (2002)
  • [96] Suksomboon N., Poolsup N., Yuwanakorn A., Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes, J Clin Pharm Ther, 39, pp. 292-306, (2014)
  • [97] Guimaraes M.M., Carvalho A.C.M.S., Silva M.S., Effect of chromium supplementation on the glucose homeostasis and anthropometry of type 2 diabetic patients: double blind, randomized clinical trial: chromium, glucose homeostasis and anthropometry, J Trace Elem Med Biol, 36, pp. 65-72, (2016)
  • [98] Paiva A.N., de Lima J.G., de Medeiros A.C.Q., Figueiredo H.A.O., de Andrade R.L., Ururahy M.A.G., Et al., Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: a randomized clinical study, J Trace Elem Med Biol, 32, pp. 66-72, (2015)
  • [99] Davis C.M., Vincent J.B., Chromium oligopeptide activates insulin receptor tyrosine kinase activity, Biochemistry, 36, pp. 4382-4385, (1997)
  • [100] Samitz M.H., Katz S.A., Scheiner D.M., Gross P.R., Chromium-protein interactions, Acta Derm Venereol, 49, pp. 142-146, (1969)
567891011121314